Transgene SA

ENXTPA:TNG Stock Report

Market Cap: €146.3m

Transgene Future Growth

Future criteria checks 2/6

Transgene's earnings are forecast to decline at 4.6% per annum while its annual revenue is expected to grow at 34.6% per year. EPS is expected to decline by 3.9% per annum.

Key information

-4.6%

Earnings growth rate

-3.85%

EPS growth rate

Biotechs earnings growth33.9%
Revenue growth rate34.6%
Future return on equityn/a
Analyst coverage

Low

Last updated17 Sep 2025

Recent future growth updates

Recent updates

Is Transgene (EPA:TNG) Using Too Much Debt?

May 27
Is Transgene (EPA:TNG) Using Too Much Debt?
User avatar

TG4050 Trial And Pipeline Developments Will Transform Cancer Vaccines

Progress in TG4050 trials could establish Transgene as a leader in cancer vaccines, boosting reputation and revenue opportunities.

Is Transgene (EPA:TNG) Using Too Much Debt?

Jun 15
Is Transgene (EPA:TNG) Using Too Much Debt?

Downgrade: Here's How Analysts See Transgene SA (EPA:TNG) Performing In The Near Term

Mar 21
Downgrade: Here's How Analysts See Transgene SA (EPA:TNG) Performing In The Near Term

Transgene SA (EPA:TNG) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mar 19
Transgene SA (EPA:TNG) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Does Transgene (EPA:TNG) Have A Healthy Balance Sheet?

Mar 18
Does Transgene (EPA:TNG) Have A Healthy Balance Sheet?

Transgene (EPA:TNG) Has Debt But No Earnings; Should You Worry?

Nov 24
Transgene (EPA:TNG) Has Debt But No Earnings; Should You Worry?

Health Check: How Prudently Does Transgene (EPA:TNG) Use Debt?

Apr 16
Health Check: How Prudently Does Transgene (EPA:TNG) Use Debt?

What Type Of Shareholders Own The Most Number of Transgene SA (EPA:TNG) Shares?

Mar 12
What Type Of Shareholders Own The Most Number of Transgene SA (EPA:TNG) Shares?

Does Transgene's (EPA:TNG) Share Price Gain of 62% Match Its Business Performance?

Jan 23
Does Transgene's (EPA:TNG) Share Price Gain of 62% Match Its Business Performance?

Earnings and Revenue Growth Forecasts

ENXTPA:TNG - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202725-40-55-302
12/31/20267-43-32-332
12/31/20257-36-32-372
6/30/20258-37-24-23N/A
3/31/20257-35-25-23N/A
12/31/20246-34-27-24N/A
9/30/20246-28-33-30N/A
6/30/20246-23-39-36N/A
3/31/20247-23-38-35N/A
12/31/20238-22-37-35N/A
9/30/20238-28-36-34N/A
6/30/20239-33-35-33N/A
3/31/202310-33-28-26N/A
12/31/202210-33-22-20N/A
9/30/202214-28-18-17N/A
6/30/202218-23-15-15N/A
3/31/202218-21-21-20N/A
12/31/202117-20-27-26N/A
9/30/202113-23-29-28N/A
6/30/20219-27-31-30N/A
3/31/20219-22-30-29N/A
12/31/202010-17-30-29N/A
9/30/202012-11-31-30N/A
6/30/202014-6-33-31N/A
3/31/202014-12-28-27N/A
12/31/201913-19-24-22N/A
9/30/201911-6-24-23N/A
6/30/201988-23-23N/A
3/31/201988N/A-25N/A
12/31/201878N/A-28N/A
9/30/20187-10N/A-29N/A
6/30/20187-29N/A-30N/A
3/31/20187-31N/A-33N/A
12/31/20177-32N/A-35N/A
9/30/20178-32N/A-36N/A
6/30/20179-31N/A-37N/A
3/31/20179-28N/A-35N/A
12/31/201610-24N/A-34N/A
9/30/201610-26N/A-37N/A
6/30/20169-28N/A-40N/A
3/31/20169-33N/A-43N/A
12/31/201510-38N/A-45N/A
9/30/201510-40N/A-48N/A
6/30/201510-42N/A-50N/A
3/31/201511-41N/A-52N/A
12/31/201411-41N/A-54N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TNG is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TNG is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TNG is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TNG's revenue (34.6% per year) is forecast to grow faster than the French market (5.5% per year).

High Growth Revenue: TNG's revenue (34.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if TNG's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/03 17:53
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Transgene SA is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Arsene GuekamCIC Market Solutions (ESN)
Michael Thomas CooperEdison Investment Research
Thomas GuillotKepler Cheuvreux